rs17620142

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_024854.5(PYROXD1):​c.85-295G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0321 in 152,142 control chromosomes in the GnomAD database, including 114 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.032 ( 114 hom., cov: 32)

Consequence

PYROXD1
NM_024854.5 intron

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.628

Publications

0 publications found
Variant links:
Genes affected
PYROXD1 (HGNC:26162): (pyridine nucleotide-disulphide oxidoreductase domain 1) This gene encodes a nuclear-cytoplasmic pyridine nucleotide-disulphide reductase (PNDR). PNDRs are flavoproteins that catalyze the pyridine nucleotide-dependent reduction of thiol residues in other proteins. The encoded protein belongs to the class I pyridine nucleotide-disulphide oxidoreductase family but lacks the C-terminal dimerization domain found in other family members and instead has a C-terminal nitrile reductase domain. It localizes to the nucleus and to striated sarcomeric compartments. Naturally occurring mutations in this gene cause early-onset myopathy with internalized nuclei and myofibrillar disorganization. A pseudogene of this gene has been defined on chromosome 11. [provided by RefSeq, Apr 2017]
PYROXD1 Gene-Disease associations (from GenCC):
  • myofibrillar myopathy 8
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 12-21440073-G-C is Benign according to our data. Variant chr12-21440073-G-C is described in ClinVar as Likely_benign. ClinVar VariationId is 1203918.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0321 (4890/152142) while in subpopulation NFE AF = 0.0481 (3273/67996). AF 95% confidence interval is 0.0468. There are 114 homozygotes in GnomAd4. There are 2284 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 114 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_024854.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PYROXD1
NM_024854.5
MANE Select
c.85-295G>C
intron
N/ANP_079130.2Q8WU10-1
PYROXD1
NM_001350912.2
c.-129-295G>C
intron
N/ANP_001337841.1Q8WU10-2
PYROXD1
NM_001350913.2
c.-619-295G>C
intron
N/ANP_001337842.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PYROXD1
ENST00000240651.14
TSL:1 MANE Select
c.85-295G>C
intron
N/AENSP00000240651.9Q8WU10-1
PYROXD1
ENST00000544970.5
TSL:1
n.85-295G>C
intron
N/AENSP00000439106.1B4DEW4
PYROXD1
ENST00000887643.1
c.85-295G>C
intron
N/AENSP00000557702.1

Frequencies

GnomAD3 genomes
AF:
0.0322
AC:
4896
AN:
152024
Hom.:
114
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00841
Gnomad AMI
AF:
0.0471
Gnomad AMR
AF:
0.0394
Gnomad ASJ
AF:
0.0585
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.0315
Gnomad FIN
AF:
0.0135
Gnomad MID
AF:
0.0759
Gnomad NFE
AF:
0.0481
Gnomad OTH
AF:
0.0506
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0321
AC:
4890
AN:
152142
Hom.:
114
Cov.:
32
AF XY:
0.0307
AC XY:
2284
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.00839
AC:
348
AN:
41496
American (AMR)
AF:
0.0393
AC:
601
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0585
AC:
203
AN:
3470
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5176
South Asian (SAS)
AF:
0.0310
AC:
149
AN:
4814
European-Finnish (FIN)
AF:
0.0135
AC:
143
AN:
10582
Middle Eastern (MID)
AF:
0.0680
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
0.0481
AC:
3273
AN:
67996
Other (OTH)
AF:
0.0510
AC:
108
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
245
491
736
982
1227
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0129
Hom.:
2
Bravo
AF:
0.0330
Asia WGS
AF:
0.0130
AC:
44
AN:
3476

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.47
DANN
Benign
0.78
PhyloP100
-0.63
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17620142; hg19: chr12-21593007; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.